niceritrol has been researched along with Hyperlipoproteinemia Type II in 3 studies
Niceritrol: An ester of nicotinic acid that lowers cholesterol and triglycerides in total plasma and in the VLD- and LD-lipoprotein fractions.
Hyperlipoproteinemia Type II: A group of familial disorders characterized by elevated circulating cholesterol contained in either LOW-DENSITY LIPOPROTEINS alone or also in VERY-LOW-DENSITY LIPOPROTEINS (pre-beta lipoproteins).
Excerpt | Relevance | Reference |
---|---|---|
"Seventeen patients with heterozygous familial hypercholesterolemia were sequentially treated with: a low cholesterol, fat restricted diet; diet and probucol (500 mg/day); and diet, probucol and niceritrol (1500 mg/day)." | 1.28 | New combined therapy of niceritrol and probucol on heterozygous familial hypercholesterolemia. ( Fukushima, N; Ozaki, I; Sakai, T; Setoguchi, Y; Yamamoto, K; Yanagita, T, 1991) |
"Niceritrol treatment significantly reduced the Chol/TG ratio in VLDL while no such effect was seen during clofibrate administration." | 1.26 | Pronounced lipoprotein lipid reduction obtained by combined lipid-lowering treatment in patients with atherosclerotic disease. ( Borberg, J; Gustafsson, IB; Lithell, H; Vessby, B, 1979) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kibata, M | 1 |
Ishida, M | 1 |
Asano, K | 1 |
Uehara, H | 1 |
Saito, K | 1 |
Fuchimoto, T | 1 |
Ugaki, K | 1 |
Murakami, H | 1 |
Matoba, K | 1 |
Kotakemori, Y | 1 |
Shirai, K | 1 |
Yoshioka, H | 1 |
Nanba, M | 1 |
Yasuda, M | 1 |
Ishizaki, M | 1 |
Kitagawa, N | 1 |
Ikejiri, K | 1 |
Inohara, R | 1 |
Lee, BJ | 1 |
Saino, S | 1 |
Sakado, J | 1 |
Matuzaka, H | 1 |
Numata, K | 1 |
Mandai, M | 1 |
Miyake, K | 1 |
Nakamura, K | 1 |
Vessby, B | 1 |
Lithell, H | 1 |
Gustafsson, IB | 1 |
Borberg, J | 1 |
Yamamoto, K | 1 |
Fukushima, N | 1 |
Ozaki, I | 1 |
Setoguchi, Y | 1 |
Yanagita, T | 1 |
Sakai, T | 1 |
3 other studies available for niceritrol and Hyperlipoproteinemia Type II
Article | Year |
---|---|
Clinical study of niceritrol on serum lipids in the treatment of hyperlipidemia.
Topics: Cholesterol; Female; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Hypolipide | 1980 |
Pronounced lipoprotein lipid reduction obtained by combined lipid-lowering treatment in patients with atherosclerotic disease.
Topics: Adult; Aged; Arteriosclerosis; Clofibrate; Female; Humans; Hyperlipoproteinemia Type II; Hyperlipopr | 1979 |
New combined therapy of niceritrol and probucol on heterozygous familial hypercholesterolemia.
Topics: Adult; Aged; Apolipoproteins A; Apolipoproteins B; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; | 1991 |